{"product_id":"home-infusion-therapy-owner-makes","title":"How Much Home Infusion Therapy Owners Make at $55M Revenue","description":"\u003cbr\u003e\u003cdiv class=\"card_smpl\"\u003e\n\n\u003cdiv class=\"double_border\"\u003e\n\n\u003cdiv class=\"card_smpl_header\"\u003e\n\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-Orange-blog-plus-icon.svg\" alt=\"Key Takeaways\" class=\"icon_how_to_use\"\u003e\n\n\u003ch3\u003eKey Takeaways\u003c\/h3\u003e\n\n\u003c\/div\u003e\n\n\u003cul class=\"lst_crct_blog\"\u003e\n\n\u003cli\u003eHigher census matters only after fixed costs are covered.\u003c\/li\u003e\n\n\u003cli\u003eBilling speed and denials drive cash, not just revenue.\u003c\/li\u003e\n\n\u003cli\u003eDrug and supply control protects margin across therapies.\u003c\/li\u003e\n\n\u003cli\u003eRouting and scheduling turn visits into real profit.\u003c\/li\u003e\n\n\u003c\/ul\u003e\n\n\u003c\/div\u003e\n\n\u003c\/div\u003e\u003cbr\u003e\u003cbr\u003e\u003csection class=\"fml-owner-metric-cards\" aria-label=\"Home infusion therapy\"\u003e\u003cdiv class=\"metric-grid\"\u003e\n\u003carticle class=\"metric-card is-green\"\u003e\u003cspan class=\"metric-icon-tip\" tabindex=\"0\" data-tooltip=\"Year 1 to Year 5 EBITDA is the pre-tax owner-pay proxy; it excludes debt service, reinvestment, reserves, and personal taxes.\"\u003e\u003cimg class=\"metric-icon\" src=\"\/cdn\/shop\/files\/fml-owner-income-kpi-owner-income.svg\" alt=\"Owner income icon\" loading=\"lazy\"\u003e\u003c\/span\u003e\u003cspan\u003eOwner income\u003c\/span\u003e\u003cstrong class=\"metric-value\" tabindex=\"0\" data-tooltip=\"Year 1 to Year 5 EBITDA is the pre-tax owner-pay proxy; it excludes debt service, reinvestment, reserves, and personal taxes.\"\u003e$3.8M–$34.1M\u003c\/strong\u003e\u003c\/article\u003e\u003carticle class=\"metric-card\"\u003e\u003cspan class=\"metric-icon-tip\" tabindex=\"0\" data-tooltip=\"EBITDA margin uses EBITDA divided by revenue in Year 1 and Year 5; it is a planning estimate, not after-tax profit.\"\u003e\u003cimg class=\"metric-icon\" src=\"\/cdn\/shop\/files\/fml-owner-income-kpi-net-margin.svg\" alt=\"Net margin icon\" loading=\"lazy\"\u003e\u003c\/span\u003e\u003cspan\u003eNet margin\u003c\/span\u003e\u003cstrong class=\"metric-value\" tabindex=\"0\" data-tooltip=\"EBITDA margin uses EBITDA divided by revenue in Year 1 and Year 5; it is a planning estimate, not after-tax profit.\"\u003e69%–79%\u003c\/strong\u003e\u003c\/article\u003e\u003carticle class=\"metric-card\"\u003e\u003cspan class=\"metric-icon-tip\" tabindex=\"0\" data-tooltip=\"Annual revenue range that supports the modeled owner-pay capacity in Year 1 to Year 5; it follows the forecast, not a guarantee.\"\u003e\u003cimg class=\"metric-icon\" src=\"\/cdn\/shop\/files\/fml-owner-income-kpi-revenue-target.svg\" alt=\"Revenue for target pay icon\" loading=\"lazy\"\u003e\u003c\/span\u003e\u003cspan\u003eRevenue for target pay\u003c\/span\u003e\u003cstrong class=\"metric-value\" tabindex=\"0\" data-tooltip=\"Annual revenue range that supports the modeled owner-pay capacity in Year 1 to Year 5; it follows the forecast, not a guarantee.\"\u003e$5.5M–$43.0M\u003c\/strong\u003e\u003c\/article\u003e\u003carticle class=\"metric-card is-yellow\"\u003e\u003cspan class=\"metric-icon-tip\" tabindex=\"0\" data-tooltip=\"Launch needs $905k minimum cash and heavy staffing, but breakeven starts in Month 1; hiring and compliance stay the main risks.\"\u003e\u003cimg class=\"metric-icon\" src=\"\/cdn\/shop\/files\/fml-owner-income-kpi-business-difficulty.svg\" alt=\"Business difficulty icon\" loading=\"lazy\"\u003e\u003c\/span\u003e\u003cspan\u003eBusiness difficulty\u003c\/span\u003e\u003cstrong class=\"metric-value\" tabindex=\"0\" data-tooltip=\"Launch needs $905k minimum cash and heavy staffing, but breakeven starts in Month 1; hiring and compliance stay the main risks.\"\u003eMedium\u003c\/strong\u003e\u003c\/article\u003e\n\u003c\/div\u003e\u003c\/section\u003e\u003cbr\u003e\u003ch2\u003e\u003cspan style=\"color: #126CFF;\"\u003eWant to test your owner take-home?\n\u003c\/span\u003e\u003c\/h2\u003e\n\u003csection class=\"fml-owner-calculator\" aria-label=\"Home Infusion Therapy Service Owner Income Calculator\" data-locale=\"en-US\" data-currency=\"USD\" data-default-scenario=\"base\" data-export-filename=\"Home Infusion Therapy Service Owner Income Calculator.xlsx\" data-source-site-name=\"Financial Models Lab\" data-source-site-url=\"https:\/\/financialmodelslab.com\" data-source-page-title=\"Home Infusion Therapy Service Owner Income Calculator\" data-note-title=\"Planning note:\" data-note-text=\"This is a researched planning estimate only, not guaranteed salary, tax advice, or owner distribution advice. Actual owner income depends on revenue, margins, payroll, taxes, debt, and reinvestment.\"\u003e\u003cdiv class=\"fml-owner-card\"\u003e\n\u003cheader class=\"fml-owner-header\"\u003e\u003cdiv class=\"fml-owner-heading\"\u003e\n\u003cp class=\"fml-owner-eyebrow\"\u003eOwner income calculator\u003c\/p\u003e\n\u003cp class=\"fml-owner-intro\"\u003eEstimate owner take-home and target-pay gap from revenue, margin, costs, reserves, and target pay.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"fml-owner-scenarios\" aria-label=\"Income scenario presets\"\u003e\n\u003cbutton class=\"fml-owner-scenario\" type=\"button\" data-scenario=\"low\"\u003eLow\u003c\/button\u003e\u003cbutton class=\"fml-owner-scenario is-active\" type=\"button\" data-scenario=\"base\"\u003eBase\u003c\/button\u003e\u003cbutton class=\"fml-owner-scenario\" type=\"button\" data-scenario=\"high\"\u003eHigh\u003c\/button\u003e\n\u003c\/div\u003e\u003c\/header\u003e\u003cdiv class=\"fml-owner-layout\"\u003e\n\u003cform class=\"fml-owner-inputs\"\u003e\n\u003cdiv class=\"fml-owner-row\"\u003e\n\u003clabel class=\"fml-owner-label\"\u003e\u003cspan\u003eMonthly revenue\u003c\/span\u003e\u003cspan class=\"fml-owner-tooltip\" tabindex=\"0\" aria-label=\"Monthly collections before expenses. Use the average operating month for the selected scenario.\"\u003ei\u003cspan role=\"tooltip\"\u003eMonthly collections before expenses. Use the average operating month for the selected scenario.\u003c\/span\u003e\u003c\/span\u003e\u003c\/label\u003e\u003cdiv class=\"fml-owner-money\"\u003e\n\u003cspan\u003e$\u003c\/span\u003e\u003cinput data-owner-field=\"monthlyRevenue\" data-owner-kind=\"money\" data-owner-label=\"Monthly revenue\" data-owner-note=\"Monthly collections before expenses. Use the average operating month for the selected scenario.\" data-low=\"455583\" data-base=\"1477333\" data-high=\"3584667\" name=\"monthlyRevenue\" type=\"text\" inputmode=\"numeric\" value=\"1,477,333\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"fml-owner-row\"\u003e\n\u003clabel class=\"fml-owner-label\"\u003e\u003cspan\u003eGross margin\u003c\/span\u003e\u003cspan class=\"fml-owner-tooltip\" tabindex=\"0\" aria-label=\"Percent of revenue left after drug, supply, nursing visit, and pharmacy costs.\"\u003ei\u003cspan role=\"tooltip\"\u003ePercent of revenue left after drug, supply, nursing visit, and pharmacy costs.\u003c\/span\u003e\u003c\/span\u003e\u003c\/label\u003e\u003cdiv class=\"fml-owner-percent\"\u003e\n\u003cinput data-owner-field=\"grossMargin\" data-owner-kind=\"percent\" data-owner-label=\"Gross margin\" data-owner-note=\"Percent of revenue left after drug, supply, nursing visit, and pharmacy costs.\" name=\"grossMargin\" type=\"range\" min=\"0\" max=\"100\" step=\"1\" data-low=\"79\" data-base=\"81\" data-high=\"83\" value=\"81\"\u003e\u003coutput\u003e81%\u003c\/output\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"fml-owner-row\"\u003e\n\u003clabel class=\"fml-owner-label\"\u003e\u003cspan\u003eLabor cost\u003c\/span\u003e\u003cspan class=\"fml-owner-tooltip\" tabindex=\"0\" aria-label=\"Monthly payroll for clinical and admin staff before owner pay.\"\u003ei\u003cspan role=\"tooltip\"\u003eMonthly payroll for clinical and admin staff before owner pay.\u003c\/span\u003e\u003c\/span\u003e\u003c\/label\u003e\u003cdiv class=\"fml-owner-money\"\u003e\n\u003cspan\u003e$\u003c\/span\u003e\u003cinput data-owner-field=\"laborCost\" data-owner-kind=\"money\" data-owner-label=\"Labor cost\" data-owner-note=\"Monthly payroll for clinical and admin staff before owner pay.\" data-low=\"39750\" data-base=\"59500\" data-high=\"87167\" name=\"laborCost\" type=\"text\" inputmode=\"numeric\" value=\"59,500\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"fml-owner-row\"\u003e\n\u003clabel class=\"fml-owner-label\"\u003e\u003cspan\u003eFixed overhead\u003c\/span\u003e\u003cspan class=\"fml-owner-tooltip\" tabindex=\"0\" aria-label=\"Monthly rent, software, insurance, compliance, telecom, and other recurring overhead, excluding marketing.\"\u003ei\u003cspan role=\"tooltip\"\u003eMonthly rent, software, insurance, compliance, telecom, and other recurring overhead, excluding marketing.\u003c\/span\u003e\u003c\/span\u003e\u003c\/label\u003e\u003cdiv class=\"fml-owner-money\"\u003e\n\u003cspan\u003e$\u003c\/span\u003e\u003cinput data-owner-field=\"fixedOverhead\" data-owner-kind=\"money\" data-owner-label=\"Fixed overhead\" data-owner-note=\"Monthly rent, software, insurance, compliance, telecom, and other recurring overhead, excluding marketing.\" data-low=\"14600\" data-base=\"14600\" data-high=\"14600\" name=\"fixedOverhead\" type=\"text\" inputmode=\"numeric\" value=\"14,600\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"fml-owner-row\"\u003e\n\u003clabel class=\"fml-owner-label\"\u003e\u003cspan\u003eMarketing\u003c\/span\u003e\u003cspan class=\"fml-owner-tooltip\" tabindex=\"0\" aria-label=\"Monthly referral development and patient acquisition spend.\"\u003ei\u003cspan role=\"tooltip\"\u003eMonthly referral development and patient acquisition spend.\u003c\/span\u003e\u003c\/span\u003e\u003c\/label\u003e\u003cdiv class=\"fml-owner-money\"\u003e\n\u003cspan\u003e$\u003c\/span\u003e\u003cinput data-owner-field=\"marketing\" data-owner-kind=\"money\" data-owner-label=\"Marketing\" data-owner-note=\"Monthly referral development and patient acquisition spend.\" data-low=\"3500\" data-base=\"4500\" data-high=\"6000\" name=\"marketing\" type=\"text\" inputmode=\"numeric\" value=\"4,500\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"fml-owner-row\"\u003e\n\u003clabel class=\"fml-owner-label\"\u003e\u003cspan\u003eDebt service\u003c\/span\u003e\u003cspan class=\"fml-owner-tooltip\" tabindex=\"0\" aria-label=\"Monthly loan or financing payments, if any.\"\u003ei\u003cspan role=\"tooltip\"\u003eMonthly loan or financing payments, if any.\u003c\/span\u003e\u003c\/span\u003e\u003c\/label\u003e\u003cdiv class=\"fml-owner-money\"\u003e\n\u003cspan\u003e$\u003c\/span\u003e\u003cinput data-owner-field=\"debtService\" data-owner-kind=\"money\" data-owner-label=\"Debt service\" data-owner-note=\"Monthly loan or financing payments, if any.\" data-low=\"0\" data-base=\"0\" data-high=\"0\" name=\"debtService\" type=\"text\" inputmode=\"numeric\" value=\"\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"fml-owner-row\"\u003e\n\u003clabel class=\"fml-owner-label\"\u003e\u003cspan\u003eTax reserve\u003c\/span\u003e\u003cspan class=\"fml-owner-tooltip\" tabindex=\"0\" aria-label=\"Percent of profit held back for taxes before owner take-home.\"\u003ei\u003cspan role=\"tooltip\"\u003ePercent of profit held back for taxes before owner take-home.\u003c\/span\u003e\u003c\/span\u003e\u003c\/label\u003e\u003cdiv class=\"fml-owner-percent\"\u003e\n\u003cinput data-owner-field=\"taxReserve\" data-owner-kind=\"percent\" data-owner-label=\"Tax reserve\" data-owner-note=\"Percent of profit held back for taxes before owner take-home.\" name=\"taxReserve\" type=\"range\" min=\"0\" max=\"45\" step=\"1\" data-low=\"20\" data-base=\"24\" data-high=\"28\" value=\"24\"\u003e\u003coutput\u003e24%\u003c\/output\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"fml-owner-row\"\u003e\n\u003clabel class=\"fml-owner-label\"\u003e\u003cspan\u003eReinvestment reserve\u003c\/span\u003e\u003cspan class=\"fml-owner-tooltip\" tabindex=\"0\" aria-label=\"Percent of profit kept for working capital, growth, and risk buffer.\"\u003ei\u003cspan role=\"tooltip\"\u003ePercent of profit kept for working capital, growth, and risk buffer.\u003c\/span\u003e\u003c\/span\u003e\u003c\/label\u003e\u003cdiv class=\"fml-owner-percent\"\u003e\n\u003cinput data-owner-field=\"reinvestmentReserve\" data-owner-kind=\"percent\" data-owner-label=\"Reinvestment reserve\" data-owner-note=\"Percent of profit kept for working capital, growth, and risk buffer.\" name=\"reinvestmentReserve\" type=\"range\" min=\"0\" max=\"35\" step=\"1\" data-low=\"5\" data-base=\"8\" data-high=\"10\" value=\"8\"\u003e\u003coutput\u003e8%\u003c\/output\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"fml-owner-row\"\u003e\n\u003clabel class=\"fml-owner-label\"\u003e\u003cspan\u003eTarget owner pay\u003c\/span\u003e\u003cspan class=\"fml-owner-tooltip\" tabindex=\"0\" aria-label=\"Monthly owner income goal used to calculate the target-pay gap.\"\u003ei\u003cspan role=\"tooltip\"\u003eMonthly owner income goal used to calculate the target-pay gap.\u003c\/span\u003e\u003c\/span\u003e\u003c\/label\u003e\u003cdiv class=\"fml-owner-money\"\u003e\n\u003cspan\u003e$\u003c\/span\u003e\u003cinput data-owner-field=\"targetOwnerPay\" data-owner-kind=\"money\" data-owner-label=\"Target owner pay\" data-owner-note=\"Monthly owner income goal used to calculate the target-pay gap.\" data-low=\"15000\" data-base=\"25000\" data-high=\"40000\" name=\"targetOwnerPay\" type=\"text\" inputmode=\"numeric\" value=\"25,000\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/form\u003e\n\u003caside class=\"fml-owner-results\" aria-live=\"polite\"\u003e\u003cspan class=\"fml-owner-tag\"\u003eOwner income output\u003c\/span\u003e\u003cdiv class=\"fml-owner-metrics\"\u003e\n\u003cdiv class=\"fml-owner-metric is-primary\"\u003e\n\u003cspan class=\"fml-owner-metric-label\"\u003eOwner Income\u003cspan class=\"fml-owner-tooltip\" tabindex=\"0\" aria-label=\"Monthly take-home after tax and reinvestment reserves.\"\u003ei\u003cspan role=\"tooltip\"\u003eMonthly take-home after tax and reinvestment reserves.\u003c\/span\u003e\u003c\/span\u003e\u003c\/span\u003e\u003cstrong data-owner-output=\"monthlyOwnerIncome\"\u003e$760K\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"fml-owner-metric\"\u003e\n\u003cspan class=\"fml-owner-metric-label\"\u003eNet Margin\u003cspan class=\"fml-owner-tooltip\" tabindex=\"0\" aria-label=\"Owner income divided by monthly revenue.\"\u003ei\u003cspan role=\"tooltip\"\u003eOwner income divided by monthly revenue.\u003c\/span\u003e\u003c\/span\u003e\u003c\/span\u003e\u003cstrong data-owner-output=\"netProfitMargin\"\u003e51%\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"fml-owner-metric\"\u003e\n\u003cspan class=\"fml-owner-metric-label\"\u003eRevenue for Target Pay\u003cspan class=\"fml-owner-tooltip\" tabindex=\"0\" aria-label=\"Monthly revenue needed to support the target owner pay.\"\u003ei\u003cspan role=\"tooltip\"\u003eMonthly revenue needed to support the target owner pay.\u003c\/span\u003e\u003c\/span\u003e\u003c\/span\u003e\u003cstrong data-owner-output=\"revenueNeeded\"\u003e$142K\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"fml-owner-metric is-target-gap is-positive\"\u003e\n\u003cspan class=\"fml-owner-metric-label\"\u003eTarget Pay Gap\u003cspan class=\"fml-owner-tooltip\" tabindex=\"0\" aria-label=\"Owner income minus target owner pay. Negative means the target pay is not covered.\"\u003ei\u003cspan role=\"tooltip\"\u003eOwner income minus target owner pay. Negative means the target pay is not covered.\u003c\/span\u003e\u003c\/span\u003e\u003c\/span\u003e\u003cstrong data-owner-output=\"targetPayGap\"\u003e$735K\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdl class=\"fml-owner-result-list\"\u003e\n\u003cdiv\u003e\n\u003cdt\u003eAnnual owner income\u003c\/dt\u003e\n\u003cdd data-owner-output=\"annualOwnerIncome\"\u003e$9,123,201\u003c\/dd\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\n\u003cdt\u003eProfit before reserves\u003c\/dt\u003e\n\u003cdd data-owner-output=\"profitBeforeReserves\"\u003e$1,118,040\u003c\/dd\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\n\u003cdt\u003eTax + reinvestment reserve\u003c\/dt\u003e\n\u003cdd data-owner-output=\"reserveAmount\"\u003e$357,773\u003c\/dd\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\n\u003cdt\u003eTarget pay gap\u003c\/dt\u003e\n\u003cdd data-owner-output=\"cashAfterTargetPay\"\u003e$735,267\u003c\/dd\u003e\n\u003c\/div\u003e\n\u003c\/dl\u003e\n\u003cdiv class=\"fml-owner-bridge\"\u003e\n\u003cdiv class=\"fml-owner-bar-row\" data-owner-bridge=\"revenue\"\u003e\n\u003cspan\u003eRevenue\u003c\/span\u003e\u003cdiv\u003e\u003ci style=\"--fml-owner-share: 100%;\"\u003e\u003c\/i\u003e\u003c\/div\u003e\n\u003cb data-owner-bridge-value\u003e$1.5M\u003c\/b\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"fml-owner-bar-row\" data-owner-bridge=\"grossProfit\"\u003e\n\u003cspan\u003eGross profit\u003c\/span\u003e\u003cdiv\u003e\u003ci style=\"--fml-owner-share: 81%;\"\u003e\u003c\/i\u003e\u003c\/div\u003e\n\u003cb data-owner-bridge-value\u003e$1.2M\u003c\/b\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"fml-owner-bar-row\" data-owner-bridge=\"operatingCosts\"\u003e\n\u003cspan\u003eOperating costs\u003c\/span\u003e\u003cdiv\u003e\u003ci style=\"--fml-owner-share: 5%;\"\u003e\u003c\/i\u003e\u003c\/div\u003e\n\u003cb data-owner-bridge-value\u003e$78,600\u003c\/b\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"fml-owner-bar-row\" data-owner-bridge=\"reserveAmount\"\u003e\n\u003cspan\u003eReserves\u003c\/span\u003e\u003cdiv\u003e\u003ci style=\"--fml-owner-share: 24%;\"\u003e\u003c\/i\u003e\u003c\/div\u003e\n\u003cb data-owner-bridge-value\u003e$358K\u003c\/b\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"fml-owner-bar-row\" data-owner-bridge=\"ownerIncome\"\u003e\n\u003cspan\u003eOwner income\u003c\/span\u003e\u003cdiv\u003e\u003ci style=\"--fml-owner-share: 51%;\"\u003e\u003c\/i\u003e\u003c\/div\u003e\n\u003cb data-owner-bridge-value\u003e$760K\u003c\/b\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"fml-owner-export\" type=\"button\" data-owner-export\u003eEXPORT XLSX\u003c\/button\u003e\u003c\/aside\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"fml-owner-note\"\u003e\n\u003cspan class=\"fml-owner-note-icon\" aria-hidden=\"true\"\u003e!\u003c\/span\u003e\u003cp\u003e\u003cstrong\u003ePlanning note:\u003c\/strong\u003e This is a researched planning estimate only, not guaranteed salary, tax advice, or owner distribution advice. Actual owner income depends on revenue, margins, payroll, taxes, debt, and reinvestment.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003c\/section\u003e\u003cbr\u003e\u003cdiv class=\"container_new_design_blog\"\u003e\n\n\u003cdiv class=\"text-section_blog text-2_new_design_blog\"\u003e\n\n\u003cdiv class=\"line_top_blog\"\u003e\u003cbr\u003e\u003c\/div\u003e\n\n\u003ch3\u003e\u003cspan style=\"color: #126CFF;\"\u003eWant to check owner income in the Home Infusion Therapy Service model?\u003c\/span\u003e\u003c\/h3\u003e\n\n\u003cp\u003eOpen the \u003ca href=\"\/products\/home-infusion-therapy-financial-model\"\u003eHome Infusion Therapy Service Financial Model Template\u003c\/a\u003e dashboard first; it shows revenue, margin, overhead, payroll, cash need, and owner pay.\u003c\/p\u003e\n\n\u003ch4\u003eOwner-income model highlights\u003c\/h4\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003e\n\u003cstrong\u003eOwner pay\u003c\/strong\u003e scenarios\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eTherapy-line revenue\u003c\/strong\u003e outputs\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCash need\u003c\/strong\u003e and reserves\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003c\/div\u003e\n\n\u003cdiv class=\"image-section_blog image-2_new_design_blog\"\u003e\n\n\u003cdiv class=\"preview-card\" data-preview-src=\"\/cdn\/shop\/files\/home-infusion-therapy-financial-model-dashboard-financialmodelslab_02e2a754-133d-4227-b669-c72576a51d2c.webp\"\u003e\n\u003cimg class=\"preview-img\" width=\"100%\" height=\"auto\" src=\"\/cdn\/shop\/files\/home-infusion-therapy-financial-model-dashboard-financialmodelslab_02e2a754-133d-4227-b669-c72576a51d2c.webp?width=500\" alt=\"Home Infusion Therapy Service Financial Model dashboard summarizes key KPIs, runway\/cash and operational performance with a dynamic dashboard, investor-ready charts and clearer cash-flow visibility\"\u003e\n\u003cdiv class=\"preview-overlay\"\u003e\n\u003cbutton class=\"preview-btn\" type=\"button\" style=\"align-items: center; vertical-align: middle; display: inline-flex; justify-content: center; gap: 6px; line-height: 1;\"\u003e\nPREVIEW \u003csvg fill=\"#fff\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" aria-hidden=\"true\" focusable=\"false\" role=\"presentation\" viewbox=\"0 0 448 512\" width=\"14\"\u003e\u003cpath d=\"M416 176V86.63L246.6 256L416 425.4V336c0-8.844 7.156-16 16-16s16 7.156 16 16v128c0 8.844-7.156 16-16 16h-128c-8.844 0-16-7.156-16-16s7.156-16 16-16h89.38L224 278.6L54.63 448H144C152.8 448 160 455.2 160 464S152.8 480 144 480h-128C7.156 480 0 472.8 0 464v-128C0 327.2 7.156 320 16 320S32 327.2 32 336v89.38L201.4 256L32 86.63V176C32 184.8 24.84 192 16 192S0 184.8 0 176v-128C0 39.16 7.156 32 16 32h128C152.8 32 160 39.16 160 48S152.8 64 144 64H54.63L224 233.4L393.4 64H304C295.2 64 288 56.84 288 48S295.2 32 304 32h128C440.8 32 448 39.16 448 48v128C448 184.8 440.8 192 432 192S416 184.8 416 176z\"\u003e\u003c\/path\u003e\u003c\/svg\u003e\n\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\n\u003c\/div\u003e\n\u003c\/div\u003e\n\n\u003ch2\u003e\u003cspan style=\"color: #126CFF;\"\u003eWhat costs reduce home infusion therapy profit?\u003c\/span\u003e\u003c\/h2\u003e\u003cbr\u003e\n\u003cp\u003eHome Infusion Therapy Service gets squeezed hardest by medication procurement, IV kits, travel, billing, denials, waste, and nurse time; for the planning side, see \u003ca href=\"\/blogs\/write-business-plan\/home-infusion-therapy\"\u003eHow To Write A Business Plan To Launch Home Infusion Therapy Service?\u003c\/a\u003e. In Year 1, listed direct costs add up to \u003cstrong\u003e210%\u003c\/strong\u003e of revenue, with \u003cstrong\u003e85%\u003c\/strong\u003e consumables and IV kits, \u003cstrong\u003e45%\u003c\/strong\u003e specialty pharmacy procurement fees, \u003cstrong\u003e50%\u003c\/strong\u003e nurse travel and mileage, and \u003cstrong\u003e30%\u003c\/strong\u003e billing and claims fees. By Year 5, they still total \u003cstrong\u003e175%\u003c\/strong\u003e, so profit only improves if safety, procurement discipline, documentation, and scheduling all hold up.\u003c\/p\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-Orange-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eMain cost drains\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003e\n\u003cstrong\u003e85%\u003c\/strong\u003e consumables and IV kits\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003e45%\u003c\/strong\u003e specialty pharmacy procurement fees\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003e50%\u003c\/strong\u003e nurse travel and mileage\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003e30%\u003c\/strong\u003e billing and claims fees\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-Orange-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eWhat protects margin\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eKeep safety steps tight\u003c\/li\u003e\n\u003cli\u003eBuy only what each case needs\u003c\/li\u003e\n\u003cli\u003eDocument every dose and visit cleanly\u003c\/li\u003e\n\u003cli\u003ePack routes to cut idle drive time\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003ch2\u003e\u003cspan style=\"color: #126CFF;\"\u003eHow many home infusion patients are needed to pay the owner?\u003c\/span\u003e\u003c\/h2\u003e\u003cbr\u003e\n\u003cp\u003eHome Infusion Therapy Service needs about \u003cstrong\u003e160 monthly infusion treatments\u003c\/strong\u003e to cover Year 1 fixed overhead before owner pay; use episodes, not one patient count, because one active patient may need multiple visits. For the cost base behind that math, see \u003ca href=\"\/blogs\/operating-costs\/home-infusion-therapy\"\u003eWhat Are The Operating Costs Of Home Infusion Therapy Service?\u003c\/a\u003e: the model shows \u003cstrong\u003e995 monthly treatments\u003c\/strong\u003e, \u003cstrong\u003e$4.556 million\u003c\/strong\u003e in monthly revenue, and about \u003cstrong\u003e$579k\u003c\/strong\u003e in fixed overhead plus listed payroll.\u003c\/p\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-Orange-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eBreak-Even Math\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eUse \u003cstrong\u003emonthly treatments\u003c\/strong\u003e, not patients\u003c\/li\u003e\n\u003cli\u003eRevenue per treatment: about \u003cstrong\u003e$4,579\u003c\/strong\u003e\n\u003c\/li\u003e\n\u003cli\u003eContribution after listed direct costs: \u003cstrong\u003e79.0%\u003c\/strong\u003e\n\u003c\/li\u003e\n\u003cli\u003eBreak-even: \u003cstrong\u003e$579k ÷ $3,617 = 160\u003c\/strong\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-Orange-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eOwner Pay Impact\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eAdd \u003cstrong\u003e28 treatments\u003c\/strong\u003e per \u003cstrong\u003e$10k\u003c\/strong\u003e owner pay\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003e$10k\/month\u003c\/strong\u003e owner pay needs about \u003cstrong\u003e188 treatments\u003c\/strong\u003e\n\u003c\/li\u003e\n\u003cli\u003eTherapy mix can move the answer\u003c\/li\u003e\n\u003cli\u003eMore visits per patient lower patient count needed\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003ch2\u003e\u003cspan style=\"color: #126CFF;\"\u003eHow much revenue does a home infusion therapy service make per patient?\u003c\/span\u003e\u003c\/h2\u003e\u003cbr\u003e\n\u003cp\u003eA \u003cstrong\u003eHome Infusion Therapy Service\u003c\/strong\u003e does not earn one fixed amount per patient; it earns per treatment or episode, so the real number depends on the therapy mix and payer rules. In the model, Year 1 prices range from \u003cstrong\u003e$350\u003c\/strong\u003e for wound care specialist services to \u003cstrong\u003e$750\u003c\/strong\u003e for oncology certified nurse services, with weighted revenue around \u003cstrong\u003e$458\u003c\/strong\u003e per monthly treatment and about \u003cstrong\u003e$539\u003c\/strong\u003e by Year 5.\u003c\/p\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-Orange-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eWhat moves revenue\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eMedication type changes the price.\u003c\/li\u003e\n\u003cli\u003eEpisode length changes total revenue.\u003c\/li\u003e\n\u003cli\u003eNursing visits add billable value.\u003c\/li\u003e\n\u003cli\u003eSupplies can raise the ticket.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-Orange-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eWhat to check first\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eCheck \u003cstrong\u003epayer contracts\u003c\/strong\u003e before pricing.\u003c\/li\u003e\n\u003cli\u003eVerify \u003cstrong\u003eauthorization\u003c\/strong\u003e rules first.\u003c\/li\u003e\n\u003cli\u003eWatch \u003cstrong\u003ecollection rate\u003c\/strong\u003e and denials.\u003c\/li\u003e\n\u003cli\u003eConfirm local payer rules by market.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003cbr\u003e\u003cbr\u003e\n\n\u003ch2\u003e\u003cspan style=\"color: #126CFF;\"\u003eWant the six drivers that move owner income most?\n\u003c\/span\u003e\u003c\/h2\u003e\n\u003csection class=\"fml-main-income-drivers\" aria-label=\"Main income drivers for a home infusion therapy service.\"\u003e\u003carticle class=\"driver-option is-cards\"\u003e\u003cdiv class=\"main-driver-grid\"\u003e\n\u003carticle class=\"main-driver-card is-primary\"\u003e\u003cdiv class=\"main-driver-heading\"\u003e\n\u003cspan class=\"driver-rank\"\u003e1\u003c\/span\u003e\u003ch4\u003eReferral Flow\u003c\/h4\u003e\n\u003c\/div\u003e\n\u003cstrong\u003e$456K\/mo\u003c\/strong\u003e\u003cp\u003eMore referrals and active patients push Year 1 revenue to about $456K a month, so census is the fastest path to owner cash.\u003c\/p\u003e\u003c\/article\u003e\u003carticle class=\"main-driver-card\"\u003e\u003cdiv class=\"main-driver-heading\"\u003e\n\u003cspan class=\"driver-rank\"\u003e2\u003c\/span\u003e\u003ch4\u003eTherapy Mix\u003c\/h4\u003e\n\u003c\/div\u003e\n\u003cstrong\u003e$350-$850\u003c\/strong\u003e\u003cp\u003eHigher-acuity therapies pay more, with prices from $350 to $850, so mix shifts can lift income without many more visits.\u003c\/p\u003e\u003c\/article\u003e\u003carticle class=\"main-driver-card\"\u003e\u003cdiv class=\"main-driver-heading\"\u003e\n\u003cspan class=\"driver-rank\"\u003e3\u003c\/span\u003e\u003ch4\u003eCollections\u003c\/h4\u003e\n\u003c\/div\u003e\n\u003cstrong\u003e3.0%-2.2%\u003c\/strong\u003e\u003cp\u003eBilling friction cuts take-home; claims fees start at 3.0% and only drop to 2.2%, so cleaner payer work matters.\u003c\/p\u003e\u003c\/article\u003e\u003carticle class=\"main-driver-card\"\u003e\u003cdiv class=\"main-driver-heading\"\u003e\n\u003cspan class=\"driver-rank\"\u003e4\u003c\/span\u003e\u003ch4\u003eSupply Margin\u003c\/h4\u003e\n\u003c\/div\u003e\n\u003cstrong\u003e13.0%-11.1%\u003c\/strong\u003e\u003cp\u003eConsumables and pharmacy fees begin at 13.0% of sales and improve to 11.1%, so buying and waste control protect gross profit.\u003c\/p\u003e\u003c\/article\u003e\u003carticle class=\"main-driver-card\"\u003e\u003cdiv class=\"main-driver-heading\"\u003e\n\u003cspan class=\"driver-rank\"\u003e5\u003c\/span\u003e\u003ch4\u003eNurse Utilization\u003c\/h4\u003e\n\u003c\/div\u003e\n\u003cstrong\u003e45%-85%\u003c\/strong\u003e\u003cp\u003eNurse schedules and drive time decide how much capacity turns into paid work, while travel reimbursement still runs 5.0% to 4.2% of sales.\u003c\/p\u003e\u003c\/article\u003e\u003carticle class=\"main-driver-card\"\u003e\u003cdiv class=\"main-driver-heading\"\u003e\n\u003cspan class=\"driver-rank\"\u003e6\u003c\/span\u003e\u003ch4\u003eOverhead Scale\u003c\/h4\u003e\n\u003c\/div\u003e\n\u003cstrong\u003e$58K\/mo\u003c\/strong\u003e\u003cp\u003eAbout $58K a month of fixed costs, plus $905K minimum cash in Month 1, means scale has to arrive early for owner pay to grow.\u003c\/p\u003e\u003c\/article\u003e\n\u003c\/div\u003e\u003c\/article\u003e\u003c\/section\u003e\u003cbr\u003e\u003ch2\u003e\u003cspan style=\"color: #126CFF;\"\u003eHome Infusion Therapy Service Core Six Income Drivers\u003c\/span\u003e\u003c\/h2\u003e\u003cbr\u003e\u003cbr\u003e\n\u003ch3\u003e\u003cspan style=\"color: #126CFF;\"\u003eActive patient census\u003c\/span\u003e\u003c\/h3\u003e\u003cbr\u003e\n\u003cdiv class=\"container_new_design_timeline\"\u003e\n  \u003cdiv class=\"left-row1\"\u003e\n    \u003ch3\u003eActive patient census\u003c\/h3\u003e\n    \u003cp\u003e\u003cstrong\u003eActive patient census\u003c\/strong\u003e is the count of patients getting monthly infusion treatments. It matters because more treatments spread fixed overhead across more visits, so owner pay improves only after volume clears the \u003cstrong\u003e160 monthly treatments\u003c\/strong\u003e break-even point before owner pay in Year 1. The model scales from about \u003cstrong\u003e995 monthly treatments in Year 1\u003c\/strong\u003e to \u003cstrong\u003e6,658 by Year 5\u003c\/strong\u003e.\u003c\/p\u003e\n    \u003cp\u003eHere’s the quick math: if census rises but \u003cstrong\u003ecase complexity\u003c\/strong\u003e, collections, or staffing lag, margin gets thinner, not better. Referral gaps, long intake cycles, uneven nurse routing, and delayed authorizations are the main risks. More volume helps only when those parts move together.\u003c\/p\u003e\n  \u003c\/div\u003e\n  \u003cdiv class=\"right-row1\"\u003e\n    \u003cdiv class=\"tips-box\"\u003e\n      \u003ch3\u003eTrack census quality\u003c\/h3\u003e\n      \u003cp\u003eMeasure \u003cstrong\u003eactive patients\u003c\/strong\u003e, monthly treatments, referral-to-start time, authorization lag, denial rate, and nurse visits per route. Those inputs show whether volume is turning into cash, not just chart count. If starts slow down, the census number can look strong while owner income stalls.\u003c\/p\u003e\n      \u003cp\u003ePush density in the same zip codes, review routing weekly, and keep a floor above \u003cstrong\u003e160 monthly treatments\u003c\/strong\u003e before drawing owner pay. A simple rule: more patients only helps when collections and staffing rise with them.\u003c\/p\u003e\n    \u003c\/div\u003e\n  \u003c\/div\u003e\n  \u003cdiv class=\"timeline\"\u003e\u003c\/div\u003e\n  \u003cdiv class=\"step-circle step1\"\u003e1\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003cbr\u003e\u003ch3\u003e\u003cspan style=\"color: #126CFF;\"\u003eTherapy and medication mix\u003c\/span\u003e\u003c\/h3\u003e\u003cbr\u003e\n\u003cdiv class=\"container_new_design_timeline\"\u003e\n\u003cdiv class=\"right-row2\"\u003e\n\u003ch3\u003eTherapy Mix\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003eTherapy mix\u003c\/strong\u003e changes both revenue and cash. Year 1 modeled prices range from \u003cstrong\u003e$350\u003c\/strong\u003e for wound care to \u003cstrong\u003e$750\u003c\/strong\u003e for oncology certified nurse visits, with \u003cstrong\u003e$450\u003c\/strong\u003e infusion nurse specialist, \u003cstrong\u003e$600\u003c\/strong\u003e pediatric infusion nurse, and \u003cstrong\u003e$400\u003c\/strong\u003e chronic care nurse cases in between. Two clinics with the same visit count can still have very different owner pay.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eNo therapy is automatically profitable.\u003c\/strong\u003e Owner income depends on \u003cstrong\u003ecollected reimbursement minus drug cost, supplies, nurse time, travel, documentation, and waste\u003c\/strong\u003e. A higher-priced case can still hurt cash if procurement cost is high or denial risk delays payment. The real metric is net cash per completed visit, not charge per visit.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"left-row2\"\u003e\n\u003cdiv class=\"tips-box\"\u003e\n\u003ch3\u003eTrack Net Cash by Case Type\u003c\/h3\u003e\n\u003cp\u003eMeasure each therapy by \u003cstrong\u003ecases\u003c\/strong\u003e, \u003cstrong\u003echarge\u003c\/strong\u003e, \u003cstrong\u003ecollected reimbursement\u003c\/strong\u003e, \u003cstrong\u003edrug and supply cost\u003c\/strong\u003e, \u003cstrong\u003enurse time\u003c\/strong\u003e, \u003cstrong\u003etravel miles\u003c\/strong\u003e, and \u003cstrong\u003edenials\u003c\/strong\u003e. Use one report to compare whether a \u003cstrong\u003e$750\u003c\/strong\u003e oncology case really out-earns a \u003cstrong\u003e$350\u003c\/strong\u003e wound care visit after all direct costs.\u003c\/p\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003e\n\u003cstrong\u003eTrack\u003c\/strong\u003e net cash per therapy.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSeparate\u003c\/strong\u003e drug cost from labor.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eWatch\u003c\/strong\u003e denials and waste fast.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eRoute\u003c\/strong\u003e long trips to protect margin.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eIf a therapy type needs expensive procurement, long travel, or frequent rework, change pricing, staffing, or case mix before it drains owner pay.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"timeline\"\u003e\u003c\/div\u003e\n\u003cdiv class=\"step-circle step2\"\u003e2\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003cbr\u003e\u003ch3\u003e\u003cspan style=\"color: #126CFF;\"\u003ePayer mix and collections\u003c\/span\u003e\u003c\/h3\u003e\u003cbr\u003e\n\u003cdiv class=\"container_new_design_timeline\"\u003e\n  \u003cdiv class=\"left-row3\"\u003e\n    \u003ch3\u003ePayer Mix and Collections\u003c\/h3\u003e\n    \u003cp\u003eFor home infusion, owner income is tied to \u003cstrong\u003ecash collected\u003c\/strong\u003e, not just claims sent. If services are authorized, billed cleanly, and matched to viable payer contracts, the model assumes \u003cstrong\u003ebilling and claims processing fees of 30% of revenue in Year 1\u003c\/strong\u003e, improving to \u003cstrong\u003e22% by Year 5\u003c\/strong\u003e. That spread matters because every point kept in collections flows through to profit and the owner’s draw.\u003c\/p\u003e\n    \u003cp\u003eHere’s the catch: denials can shrink cash even when accounting revenue looks fine. Track \u003cstrong\u003eauthorization rate\u003c\/strong\u003e, \u003cstrong\u003edays to collect\u003c\/strong\u003e, \u003cstrong\u003edenial rate\u003c\/strong\u003e, \u003cstrong\u003ewrite-offs\u003c\/strong\u003e, and \u003cstrong\u003enet collection rate\u003c\/strong\u003e. One clean claim can pay better than three messy ones. If claims lag or denials stack up, payroll, drug buys, and owner pay all feel the squeeze fast.\u003c\/p\u003e\n  \u003c\/div\u003e\n  \u003cdiv class=\"right-row3\"\u003e\n    \u003cdiv class=\"tips-box\"\u003e\n      \u003ch3\u003eTrack Cash, Not Just Charges\u003c\/h3\u003e\n      \u003cp\u003eMeasure each step of the revenue cycle so you can fix the leak, not guess at it. Start with \u003cstrong\u003eauthorization before treatment\u003c\/strong\u003e, then watch claim lag, denial causes, and write-off patterns by payer. The goal is simple: fewer rework loops and faster cash in the bank.\u003c\/p\u003e\n      \u003cul class=\"lst_crct_blog\"\u003e\n        \u003cli\u003eTrack authorization rate weekly\u003c\/li\u003e\n        \u003cli\u003eWatch days to collect monthly\u003c\/li\u003e\n        \u003cli\u003eSplit denials by reason code\u003c\/li\u003e\n        \u003cli\u003eReview net collection rate by payer\u003c\/li\u003e\n        \u003cli\u003eCompare billed charges to cash received\u003c\/li\u003e\n      \u003c\/ul\u003e\n      \u003cp\u003eIf collections slip, owner income falls twice: first in delayed cash, then in higher billing cost. Faster collection improves working capital, which helps fund supplies, nurses, and the owner’s take-home pay without adding more volume.\u003c\/p\u003e\n    \u003c\/div\u003e\n  \u003c\/div\u003e\n  \u003cdiv class=\"timeline\"\u003e\u003c\/div\u003e\n  \u003cdiv class=\"step-circle step3\"\u003e3\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003cbr\u003e\u003ch3\u003e\u003cspan style=\"color: #126CFF;\"\u003eDrug and supply margin\u003c\/span\u003e\u003c\/h3\u003e\u003cbr\u003e\n\u003cdiv class=\"container_new_design_timeline\"\u003e\n\u003cdiv class=\"right-row4\"\u003e\n\u003ch3\u003eDrug and Supply Margin\u003c\/h3\u003e\n\u003cp\u003eIf drug and supply buying gets sloppy, margin disappears fast even when visit volume holds. In this model, Year 1 direct costs run \u003cstrong\u003e85%\u003c\/strong\u003e for medical consumables and IV kits plus \u003cstrong\u003e45%\u003c\/strong\u003e for specialty pharmacy procurement fees; by Year 5, those fall to \u003cstrong\u003e74%\u003c\/strong\u003e and \u003cstrong\u003e37%\u003c\/strong\u003e. The owner’s take-home rises only when more of each billed treatment stays after direct supply cost.\u003c\/p\u003e\n\u003cp\u003eThis driver includes drug acquisition, IV kits, consumables, waste, and unreimbursed items. The key inputs are treatment count, purchase price, reimbursement, denial rate, unusable inventory, and procurement terms. One bad batch or loose stock control can turn a high-revenue case into weak cash flow, because gross margin funds nurse pay, overhead, and owner draw.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"left-row4\"\u003e\n\u003cdiv class=\"tips-box\"\u003e\n\u003ch3\u003eControl Buy Cost and Waste\u003c\/h3\u003e\n\u003cp\u003eTrack \u003cstrong\u003eunit cost per treatment\u003c\/strong\u003e, \u003cstrong\u003ewaste rate\u003c\/strong\u003e, and \u003cstrong\u003eunreimbursed supply rate\u003c\/strong\u003e every month. Tie each case to the ordered drug, kit, and pump use, so you can spot shrink fast. \u003cstrong\u003eBarcoding\u003c\/strong\u003e, inventory checks, pump tracking, and vendor contract review protect margin; shortcuts usually just create more write-offs.\u003c\/p\u003e\n\u003cp\u003eUse the same test on every therapy line: collected revenue minus direct supply cost. If a therapy needs high-cost kits or has frequent unusable items, renegotiate terms or tighten usage rules. Here’s the quick math: if direct supply cost falls, more of each treatment can cover fixed overhead and leave profit for the owner.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"timeline\"\u003e\u003c\/div\u003e\n\u003cdiv class=\"step-circle step4\"\u003e4\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003cbr\u003e\u003ch3\u003e\u003cspan style=\"color: #126CFF;\"\u003eNursing labor utilization\u003c\/span\u003e\u003c\/h3\u003e\u003cbr\u003e\n\u003cdiv class=\"container_new_design_timeline\"\u003e\n  \u003cdiv class=\"left-row5\"\u003e\n    \u003ch3\u003eNursing Labor Utilization\u003c\/h3\u003e\n    \u003cp\u003eThis driver is about how many billable visits each nurse can complete after you account for \u003cstrong\u003etravel time\u003c\/strong\u003e, \u003cstrong\u003eafter-hours coverage\u003c\/strong\u003e, and schedule gaps. In Year 1, the model uses \u003cstrong\u003e29 revenue-producing clinicians\u003c\/strong\u003e across five service lines, with capacity rates of \u003cstrong\u003e450%\u003c\/strong\u003e to \u003cstrong\u003e700%\u003c\/strong\u003e by line. If routing is weak, paid labor turns into mileage, overtime, and lost owner draw.\u003c\/p\u003e\n    \u003cp\u003eBy Year 5, clinicians rise to \u003cstrong\u003e130\u003c\/strong\u003e and capacity reaches \u003cstrong\u003e800%\u003c\/strong\u003e to \u003cstrong\u003e850%\u003c\/strong\u003e by line, so margin depends on keeping each visit productive. Here’s the quick math: more completed visits per paid hour lifts gross margin; more unplanned drive time does the opposite. What this hides is clinical safety, licensure, and service quality, which still have to hold.\u003c\/p\u003e\n  \u003c\/div\u003e\n  \u003cdiv class=\"right-row5\"\u003e\n    \u003cdiv class=\"tips-box\"\u003e\n      \u003ch3\u003eTrack Visits per Paid Hour\u003c\/h3\u003e\n      \u003cp\u003eMeasure \u003cstrong\u003ebillable visits per clinician day\u003c\/strong\u003e, travel minutes per visit, ove\nrtime hours, and after-hours fill rate. If one nurse can cover more visits without raising overtime or burnout, owner income improves because labor cost stays closer to collected revenue. If routing pushes nurses into long drives or late calls, cash flow tightens fast.\u003c\/p\u003e\n      \u003cp\u003eUse daily dispatch rules, zip-code clustering, and shift caps to protect margin. Track: \u003cstrong\u003escheduled visits\u003c\/strong\u003e, \u003cstrong\u003ecompleted visits\u003c\/strong\u003e, \u003cstrong\u003eovertime\u003c\/strong\u003e, and \u003cstrong\u003emiles per visit\u003c\/strong\u003e. Keep licensure and care quality first, but cut dead time hard. One clean rule: fewer empty miles means more money left after payroll.\u003c\/p\u003e\n    \u003c\/div\u003e\n  \u003c\/div\u003e\n  \u003cdiv class=\"timeline\"\u003e\u003c\/div\u003e\n  \u003cdiv class=\"step-circle step5\"\u003e5\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003cbr\u003e\u003ch3\u003e\u003cspan style=\"color: #126CFF;\"\u003eFixed overhead scale\u003c\/span\u003e\u003c\/h3\u003e\u003cbr\u003e\n\u003cdiv class=\"container_new_design_timeline\"\u003e\n  \u003cdiv class=\"right-row6\"\u003e\n    \u003ch3\u003eFixed overhead scale\u003c\/h3\u003e\n    \u003cp\u003e\u003cstrong\u003eFixed overhead\u003c\/strong\u003e includes rent, liability insurance, software, marketing, compliance audits, telecom, dispatch, and payroll that do not move much with each visit. In Year 1, that base is \u003cstrong\u003e$181k per month\u003c\/strong\u003e, plus \u003cstrong\u003e$477k\u003c\/strong\u003e of payroll in Year 1. At \u003cstrong\u003e$4.556M\u003c\/strong\u003e monthly revenue, overhead is about \u003cstrong\u003e4.0%\u003c\/strong\u003e of sales; by Year 5 at \u003cstrong\u003e$359M\u003c\/strong\u003e, it falls to about \u003cstrong\u003e0.05%\u003c\/strong\u003e.\u003c\/p\u003e\n    \u003cp\u003eThat drop matters because owner pay comes after fixed bills are covered. The risk is simple: if volume, collections, or staffing slip, these costs still hit the bank account. Keep cash reserves for \u003cstrong\u003ecompliance\u003c\/strong\u003e, \u003cstrong\u003ecash timing\u003c\/strong\u003e, and \u003cstrong\u003egrowth\u003c\/strong\u003e, or the business can look profitable on paper but still strain owner draws.\u003c\/p\u003e\n  \u003c\/div\u003e\n  \u003cdiv class=\"left-row6\"\u003e\n    \u003cdiv class=\"tips-box\"\u003e\n      \u003ch3\u003eWatch the overhead ratio\u003c\/h3\u003e\n      \u003cp\u003eTrack \u003cstrong\u003efixed overhead as a percent of revenue\u003c\/strong\u003e every month, plus rent, insurance, software, marketing, audits, and dispatch payroll by line item. Here’s the quick math: fixed cost dollars stay mostly flat, so the owner keeps more profit as monthly revenue rises. If revenue stalls, the same \u003cstrong\u003e$181k\u003c\/strong\u003e base eats a bigger share of income fast.\u003c\/p\u003e\n      \u003cp\u003eTest whether each fixed spend earns its keep. Marketing should support referral flow, software should cut admin time, and compliance should stay current without overspend. Build a reserve before expanding headcount or space, because the payback on overhead only works when volume and collections stay ahead of the fixed bill.\u003c\/p\u003e\n    \u003c\/div\u003e\n  \u003c\/div\u003e\n  \u003cdiv class=\"timeline\"\u003e\u003c\/div\u003e\n  \u003cdiv class=\"step-circle step6\"\u003e6\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003cbr\u003e\u003cbr\u003e\u003ch2\u003e\u003cspan style=\"color: #126CFF;\"\u003eScenario objective for home infusion therapy income scenarios\n\u003c\/span\u003e\u003c\/h2\u003e\n\u003csection class=\"fml-scenario-table\" aria-label=\"Home Infusion Therapy Service Owner Income Scenarios\" data-site-name=\"Financial Models Lab\" data-site-url=\"https:\/\/financialmodelslab.com\" data-source-title=\"Home Infusion Therapy Service Owner Income Scenarios\" data-note-label=\"Planning note\" data-note-text=\"Scenario ranges are researched planning assumptions, not guaranteed earnings, salary promises, tax advice, or distributions.\"\u003e\u003cdiv class=\"fml-scenario-table-card\"\u003e\n\u003cheader class=\"fml-scenario-table-header\"\u003e\u003cdiv\u003e\n\u003cp class=\"fml-scenario-table-eyebrow\"\u003eOwner income table\u003c\/p\u003e\n\u003cp class=\"fml-scenario-table-description\"\u003eOwner income shifts with treatment volume, case mix, and nurse capacity. Fixed overhead stays meaningful, so the same service can swing a lot by Year 1, Year 3, and Year 5.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"fml-scenario-table-actions\"\u003e\u003cbutton class=\"fml-scenario-table-export\" type=\"button\" data-scenario-export\u003eEXPORT XLSX\u003c\/button\u003e\u003c\/div\u003e\u003c\/header\u003e\u003cdiv class=\"fml-scenario-table-wrap\"\u003e\u003ctable class=\"fml-scenario-table-grid\"\u003e\n\u003ccaption\u003eScenario view of likely owner income at different operating scales.\u003c\/caption\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth class=\"fml-scenario-table-stub\" scope=\"col\" data-export-value=\"Scenario\"\u003eScenario\u003c\/th\u003e\n\u003cth class=\"fml-scenario-table-column\" scope=\"col\" data-export-value=\"Low Case\"\u003e\n\u003cspan class=\"fml-scenario-column-title\"\u003eLow Case\u003c\/span\u003e\u003cspan class=\"fml-scenario-badge is-soft\"\u003eEarly scale\u003c\/span\u003e\n\u003c\/th\u003e\n\u003cth class=\"fml-scenario-table-column\" scope=\"col\" data-export-value=\"Base Case\"\u003e\n\u003cspan class=\"fml-scenario-column-title\"\u003eBase Case\u003c\/span\u003e\u003cspan class=\"fml-scenario-badge is-soft\"\u003eScaled operations\u003c\/span\u003e\n\u003c\/th\u003e\n\u003cth class=\"fml-scenario-table-column\" scope=\"col\" data-export-value=\"High Case\"\u003e\n\u003cspan class=\"fml-scenario-column-title\"\u003eHigh Case\u003c\/span\u003e\u003cspan class=\"fml-scenario-badge is-warning\"\u003eHigh-volume network\u003c\/span\u003e\n\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr data-scenario-row\u003e\n\u003cth class=\"fml-scenario-row-heading\" scope=\"row\" data-export-value=\"Launch model\"\u003e\u003cspan class=\"fml-scenario-row-heading-inner\"\u003e\u003cspan class=\"fml-scenario-row-icon is-launch\" aria-hidden=\"true\"\u003e\u003cimg class=\"fml-scenario-row-icon-img\" src=\"\/cdn\/shop\/files\/scenario-launch-model.svg\" alt=\"Launch model icon\" loading=\"lazy\"\u003e\u003c\/span\u003e\u003cspan\u003e\u003cspan class=\"fml-scenario-row-title\"\u003eLaunch model\u003c\/span\u003e\u003c\/span\u003e\u003c\/span\u003e\u003c\/th\u003e\n\u003ctd data-export-value=\"This is the early-scale case built from Year 1 assumptions.\"\u003eThis is the early-scale case built from Year 1 assumptions.\u003c\/td\u003e\n\u003ctd data-export-value=\"This is the modeled middle case built from Year 3 assumptions.\"\u003eThis is the modeled middle case built from Year 3 assumptions.\u003c\/td\u003e\n\u003ctd data-export-value=\"This is the upside case built from Year 5 assumptions.\"\u003eThis is the upside case built from Year 5 assumptions.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-scenario-row\u003e\n\u003cth class=\"fml-scenario-row-heading\" scope=\"row\" data-export-value=\"Typical setup\"\u003e\u003cspan class=\"fml-scenario-row-heading-inner\"\u003e\u003cspan class=\"fml-scenario-row-icon is-setup\" aria-hidden=\"true\"\u003e\u003cimg class=\"fml-scenario-row-icon-img\" src=\"\/cdn\/shop\/files\/scenario-typical-setup.svg\" alt=\"Typical setup icon\" loading=\"lazy\"\u003e\u003c\/span\u003e\u003cspan\u003e\u003cspan class=\"fml-scenario-row-title\"\u003eTypical setup\u003c\/span\u003e\u003c\/span\u003e\u003c\/span\u003e\u003c\/th\u003e\n\u003ctd data-export-value=\"About 995 monthly treatments, $4.56M monthly revenue, 79.0% gross margin, and about $579k monthly overhead define the launch case.\"\u003eAbout 995 monthly treatments, $4.56M monthly revenue, 79.0% gross margin, and about $579k monthly overhead define the launch case.\u003c\/td\u003e\n\u003ctd data-export-value=\"About 2,962 monthly treatments, $1.48M monthly revenue, 80.8% gross margin, and about $77.6k monthly overhead define the core case.\"\u003eAbout 2,962 monthly treatments, $1.48M monthly revenue, 80.8% gross margin, and about $77.6k monthly overhead define the core case.\u003c\/td\u003e\n\u003ctd data-export-value=\"About 6,659 monthly treatments, $3.59M monthly revenue, 82.5% gross margin, and about $105k monthly overhead define the scale case.\"\u003eAbout 6,659 monthly treatments, $3.59M monthly revenue, 82.5% gross margin, and about $105k monthly overhead define the scale case.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-scenario-row\u003e\n\u003cth class=\"fml-scenario-row-heading\" scope=\"row\" data-export-value=\"Cost drivers\"\u003e\u003cspan class=\"fml-scenario-row-heading-inner\"\u003e\u003cspan class=\"fml-scenario-row-icon is-drivers\" aria-hidden=\"true\"\u003e\u003cimg class=\"fml-scenario-row-icon-img\" src=\"\/cdn\/shop\/files\/scenario-cost-drivers.svg\" alt=\"Cost drivers icon\" loading=\"lazy\"\u003e\u003c\/span\u003e\u003cspan\u003e\u003cspan class=\"fml-scenario-row-title\"\u003eCost drivers\u003c\/span\u003e\u003c\/span\u003e\u003c\/span\u003e\u003c\/th\u003e\n\u003ctd data-export-value=\"Treatment volume; case mix pricing; nurse capacity; supply costs; overhead control\"\u003e\u003cul class=\"fml-scenario-list\"\u003e\n\u003cli\u003eTreatment volume\u003c\/li\u003e\n\u003cli\u003ecase mix pricing\u003c\/li\u003e\n\u003cli\u003enurse capacity\u003c\/li\u003e\n\u003cli\u003esupply costs\u003c\/li\u003e\n\u003cli\u003eoverhead control\u003c\/li\u003e\n\u003c\/ul\u003e\u003c\/td\u003e\n\u003ctd data-export-value=\"Treatment volume; case mix pricing; nurse capacity; supply costs; overhead control\"\u003e\u003cul class=\"fml-scenario-list\"\u003e\n\u003cli\u003eTreatment volume\u003c\/li\u003e\n\u003cli\u003ecase mix pricing\u003c\/li\u003e\n\u003cli\u003enurse capacity\u003c\/li\u003e\n\u003cli\u003esupply costs\u003c\/li\u003e\n\u003cli\u003eoverhead control\u003c\/li\u003e\n\u003c\/ul\u003e\u003c\/td\u003e\n\u003ctd data-export-value=\"Treatment volume; case mix pricing; nurse capacity; supply costs; overhead control\"\u003e\u003cul class=\"fml-scenario-list\"\u003e\n\u003cli\u003eTreatment volume\u003c\/li\u003e\n\u003cli\u003ecase mix pricing\u003c\/li\u003e\n\u003cli\u003enurse capacity\u003c\/li\u003e\n\u003cli\u003esupply costs\u003c\/li\u003e\n\u003cli\u003eoverhead control\u003c\/li\u003e\n\u003c\/ul\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-scenario-row\u003e\n\u003cth class=\"fml-scenario-row-heading\" scope=\"row\" data-export-value=\"Owner income range\"\u003e\u003cspan class=\"fml-scenario-row-heading-inner\"\u003e\u003cspan class=\"fml-scenario-row-icon is-range\" aria-hidden=\"true\"\u003e\u003cimg class=\"fml-scenario-row-icon-img\" src=\"\/cdn\/shop\/files\/scenario-planning-range.svg\" alt=\"Owner income range icon\" loading=\"lazy\"\u003e\u003c\/span\u003e\u003cspan\u003e\u003cspan class=\"fml-scenario-row-title\"\u003eOwner income range\u003c\/span\u003e\u003cspan class=\"fml-scenario-row-subtitle\"\u003eBefore owner reserves\u003c\/span\u003e\u003c\/span\u003e\u003c\/span\u003e\u003c\/th\u003e\n\u003ctd data-export-value=\"$3.8M\/yr\"\u003e\n\u003cstrong class=\"fml-scenario-range\"\u003e$3.8M\/yr\u003c\/strong\u003e\u003cspan class=\"fml-scenario-badge is-soft\"\u003eLaunch case\u003c\/span\u003e\n\u003c\/td\u003e\n\u003ctd data-export-value=\"$13.5M\/yr\"\u003e\n\u003cstrong class=\"fml-scenario-range\"\u003e$13.5M\/yr\u003c\/strong\u003e\u003cspan class=\"fml-scenario-badge is-soft\"\u003eCore case\u003c\/span\u003e\n\u003c\/td\u003e\n\u003ctd data-export-value=\"$34.1M\/yr\"\u003e\n\u003cstrong class=\"fml-scenario-range\"\u003e$34.1M\/yr\u003c\/strong\u003e\u003cspan class=\"fml-scenario-badge is-warning\"\u003eUpside case\u003c\/span\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-scenario-row\u003e\n\u003cth class=\"fml-scenario-row-heading\" scope=\"row\" data-export-value=\"Best fit\"\u003e\u003cspan class=\"fml-scenario-row-heading-inner\"\u003e\u003cspan class=\"fml-scenario-row-icon is-fit\" aria-hidden=\"true\"\u003e\u003cimg class=\"fml-scenario-row-icon-img\" src=\"\/cdn\/shop\/files\/scenario-best-fit.svg\" alt=\"Best fit icon\" loading=\"lazy\"\u003e\u003c\/span\u003e\u003cspan\u003e\u003cspan class=\"fml-scenario-row-title\"\u003eBest fit\u003c\/span\u003e\u003c\/span\u003e\u003c\/span\u003e\u003c\/th\u003e\n\u003ctd data-export-value=\"Use this to test launch-month staffing and referral flow.\"\u003eUse this to test launch-month staffing and referral flow.\u003c\/td\u003e\n\u003ctd data-export-value=\"Use this as the steady-state plan after the first growth push.\"\u003eUse this as the steady-state plan after the first growth push.\u003c\/td\u003e\n\u003ctd data-export-value=\"Use this to test a larger network with strong utilization.\"\u003eUse this to test a larger network with strong utilization.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\u003c\/div\u003e\n\u003cdiv class=\"fml-scenario-table-note\"\u003e\n\u003cspan class=\"fml-scenario-table-note-icon\" aria-hidden=\"true\"\u003e!\u003c\/span\u003e\u003cp\u003e\u003cstrong\u003ePlanning note:\u003c\/strong\u003e Scenario ranges are researched planning assumptions, not guaranteed earnings, salary promises, tax advice, or distributions.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003c\/section\u003e","brand":"FinancialModelsLab","offers":[{"title":"Default Title","offer_id":49303903666419,"sku":"home-infusion-therapy-owner-makes","price":0.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0522\/6191\/2762\/files\/home-infusion-therapy-owner-makes.webp?v=1782684255","url":"https:\/\/financialmodelslab.com\/products\/home-infusion-therapy-owner-makes","provider":"Financial Models Lab","version":"1.0","type":"link"}